{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:25:00Z","timestamp":1793190300514,"version":"4.5.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-57032-0","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T07:39:17Z","timestamp":1740382757000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Individual bioenergetic capacity as a potential source of resilience to Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4666-0923","authenticated-orcid":false,"given":"Matthias","family":"Arnold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5027-5078","authenticated-orcid":false,"given":"Mustafa","family":"Buyukozkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Murali","family":"Doraiswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwangsik","family":"Nho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2296-3380","authenticated-orcid":false,"given":"Tong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5696-0084","authenticated-orcid":false,"given":"Vilmundur","family":"Gudnason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3238-7612","authenticated-orcid":false,"given":"Lenore J.","family":"Launer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8794-8229","authenticated-orcid":false,"given":"Rui","family":"Wang-Sattler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Adamski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Alzheimer\u2019s Disease Metabolomics Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8057-2505","authenticated-orcid":false,"given":"Philip L.","family":"De Jager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4436-8889","authenticated-orcid":false,"given":"Nil\u00fcfer","family":"Ertekin-Taner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1376-8532","authenticated-orcid":false,"given":"Andrew J.","family":"Saykin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9638-3912","authenticated-orcid":false,"given":"Karsten","family":"Suhre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1858-5732","authenticated-orcid":false,"given":"Rima","family":"Kaddurah-Daouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2368-7322","authenticated-orcid":false,"given":"Gabi","family":"Kastenm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4734-3791","authenticated-orcid":false,"given":"Jan","family":"Krumsiek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,24]]},"reference":[{"key":"57032_CR1","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3233\/JAD-2010-091504","volume":"20","author":"L Mosconi","year":"2010","unstructured":"Mosconi, L. et al. Pre-clinical detection of Alzheimer\u2019s disease using FDG-PET, with or without amyloid imaging. J. Alzheimers Dis. 20, 843\u2013854 (2010).","journal-title":"J. Alzheimers Dis."},{"key":"57032_CR2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2302\/kjm.38.111","volume":"38","author":"WD Heiss","year":"1989","unstructured":"Heiss, W. D. et al. Positron emission tomography findings in dementia disorders: contributions to differential diagnosis and objectivizing of therapeutic effects. Keio J. Med. 38, 111\u2013135 (1989).","journal-title":"Keio J. Med."},{"key":"57032_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1749-6632.1991.tb00192.x","volume":"640","author":"WD Heiss","year":"1991","unstructured":"Heiss, W. D., Szelies, B., Kessler, J. & Herholz, K. Abnormalities of energy metabolism in Alzheimer\u2019s disease studied with PET. Ann. N. Y. Acad. Sci. 640, 65\u201371 (1991).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"57032_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0028-3932(91)90084-L","volume":"29","author":"J Kessler","year":"1991","unstructured":"Kessler, J., Herholz, K., Grond, M. & Heiss, W. D. Impaired metabolic activation in Alzheimer\u2019s disease: a PET study during continuous visual recognition. Neuropsychologia 29, 229\u2013243 (1991).","journal-title":"Neuropsychologia"},{"key":"57032_CR5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3389\/fnins.2018.00383","volume":"12","author":"S Chatterjee","year":"2018","unstructured":"Chatterjee, S. & Mudher, A. Alzheimer\u2019s disease and type 2 diabetes: a critical assessment of the shared pathological traits. Front. Neurosci. 12, 383 (2018).","journal-title":"Front. Neurosci."},{"key":"57032_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.7762\/cnr.2018.7.4.229","volume":"7","author":"HJ Lee","year":"2018","unstructured":"Lee, H. J. et al. Diabetes and Alzheimer\u2019s disease: mechanisms and nutritional aspects. Clin. Nutr. Res. 7, 229 (2018).","journal-title":"Clin. Nutr. Res."},{"key":"57032_CR7","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/j.1749-6632.1997.tb48496.x","volume":"826","author":"CL Leibson","year":"1997","unstructured":"Leibson, C. L. et al. The risk of dementia among persons with diabetes mellitus: a population-based cohort study. Ann. N. Y. Acad. Sci. 826, 422\u2013427 (1997).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"57032_CR8","first-page":"69","volume":"7","author":"CY Santos","year":"2017","unstructured":"Santos, C. Y. et al. Pathophysiologic relationship between Alzheimer\u2019s disease, cerebrovascular disease, and cardiovascular risk: a review and synthesis. Alzheimer's Dement. 7, 69\u201387 (2017).","journal-title":"Alzheimer's Dement."},{"key":"57032_CR9","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1161\/CIRCRESAHA.118.313563","volume":"124","author":"JM Tublin","year":"2019","unstructured":"Tublin, J. M., Adelstein, J. M., Del Monte, F., Combs, C. K. & Wold, L. E. Getting to the heart of Alzheimer's disease. Circ. Res. 124, 142\u2013149 (2019).","journal-title":"Circ. Res."},{"key":"57032_CR10","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3389\/fphar.2019.00902","volume":"10","author":"G Cenini","year":"2019","unstructured":"Cenini, G. & Voos, W. Mitochondria as potential targets in Alzheimer disease therapy: an update. Front. Pharmacol. 10, 902 (2019).","journal-title":"Front. Pharmacol."},{"key":"57032_CR11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.14336\/AD.2015.1007","volume":"7","author":"IG Onyango","year":"2016","unstructured":"Onyango, I. G., Dennis, J. & Khan, S. M. Mitochondrial dysfunction in Alzheimer\u2019s disease and the rationale for bioenergetics based therapies. Aging Dis. 7, 201\u2013214 (2016).","journal-title":"Aging Dis."},{"key":"57032_CR12","doi-asserted-by":"publisher","first-page":"T61","DOI":"10.1530\/JOE-13-0397","volume":"220","author":"N Turner","year":"2014","unstructured":"Turner, N., Cooney, G. J., Kraegen, E. W. & Bruce, C. R. Fatty acid metabolism, energy expenditure and insulin resistance in muscle. J. Endocrinol. 220, T61\u2013T79 (2014).","journal-title":"J. Endocrinol."},{"key":"57032_CR13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/GIM.0b013e3181614289","volume":"10","author":"P Rinaldo","year":"2008","unstructured":"Rinaldo, P., Cowan, T. M. & Matern, D. Acylcarnitine profile analysis. Genet. Med. 10, 151\u2013156 (2008).","journal-title":"Genet. Med."},{"key":"57032_CR14","unstructured":"CDC. Using tandem mass spectrometry for metabolic disease screening among newborns. MMWR Recomm. Rep. 50, 1\u201334. https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr5003a1.htm (2001)."},{"key":"57032_CR15","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/ng.3809","volume":"49","author":"T Long","year":"2017","unstructured":"Long, T. et al. Whole-genome sequencing identifies common-to-rare variants associated with human blood metabolites. Nat. Genet. 49, 568\u2013578 (2017).","journal-title":"Nat. Genet."},{"key":"57032_CR16","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/ng.2982","volume":"46","author":"SY Shin","year":"2014","unstructured":"Shin, S. Y. et al. An atlas of genetic influences on human blood metabolites. Nat. Genet. 46, 543\u2013550 (2014).","journal-title":"Nat. Genet."},{"key":"57032_CR17","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nature10354","volume":"477","author":"K Suhre","year":"2011","unstructured":"Suhre, K. et al. Human metabolic individuality in biomedical and pharmaceutical research. Nature 477, 54\u201360 (2011).","journal-title":"Nature"},{"key":"57032_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8208","volume":"6","author":"HHM Draisma","year":"2015","unstructured":"Draisma, H. H. M. et al. Genome-wide association study identifies novel genetic variants contributing to variation in blood metabolite levels. Nat. Commun. 6, 7208 (2015).","journal-title":"Nat. Commun."},{"key":"57032_CR19","doi-asserted-by":"publisher","first-page":"885","DOI":"10.2337\/db17-1150","volume":"67","author":"B Batchuluun","year":"2018","unstructured":"Batchuluun, B. et al. Elevated medium-chain acylcarnitines are associated with gestational diabetes mellitus and early progression to type 2 diabetes and induce pancreatic \u03b2-cell dysfunction. Diabetes 67, 885\u2013897 (2018).","journal-title":"Diabetes"},{"key":"57032_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2337\/db12-0466","volume":"62","author":"MG Schooneman","year":"2013","unstructured":"Schooneman, M. G., Vaz, F. M., Houten, S. M. & Soeters, M. R. Acylcarnitines: reflecting or inflicting insulin resistance? Diabetes 62, 1\u20138 (2013).","journal-title":"Diabetes"},{"key":"57032_CR21","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cmet.2009.02.002","volume":"9","author":"CB Newgard","year":"2009","unstructured":"Newgard, C. B. et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 9, 311\u2013326 (2009).","journal-title":"Cell Metab."},{"key":"57032_CR22","doi-asserted-by":"publisher","first-page":"13555","DOI":"10.18632\/aging.103462","volume":"12","author":"ZR Jarrell","year":"2020","unstructured":"Jarrell, Z. R. et al. Plasma acylcarnitine levels increase with healthy aging. Aging 12, 13555\u201313570 (2020).","journal-title":"Aging"},{"key":"57032_CR23","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.molcel.2016.01.028","volume":"61","author":"N Sun","year":"2016","unstructured":"Sun, N., Youle, R. J. & Finkel, T. The mitochondrial basis of aging. Mol. Cell 61, 654\u2013666 (2016).","journal-title":"Mol. Cell"},{"key":"57032_CR24","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1111\/j.1474-9726.2012.00865.x","volume":"11","author":"Z Yu","year":"2012","unstructured":"Yu, Z. et al. Human serum metabolic profiles are age dependent. Aging Cell 11, 960\u2013967 (2012).","journal-title":"Aging Cell"},{"key":"57032_CR25","first-page":"103362","volume":"71","author":"CJC Huguenard","year":"2023","unstructured":"Huguenard, C. J. C. et al. APOE \u03b54 and Alzheimer\u2019s disease diagnosis associated differences in L-carnitine, GBB, TMAO, and acylcarnitines in blood and brain. Curr. Res. Transl. Med. 71, 103362 (2023).","journal-title":"Curr. Res. Transl. Med."},{"key":"57032_CR26","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nm.3466","volume":"20","author":"M Mapstone","year":"2014","unstructured":"Mapstone, M. et al. Plasma phospholipids identify antecedent memory impairment in older adults. Nat. Med. 20, 415\u2013418 (2014).","journal-title":"Nat. Med."},{"key":"57032_CR27","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.jalz.2015.12.008","volume":"12","author":"R Casanova","year":"2016","unstructured":"Casanova, R. et al. Blood metabolite markers of preclinical Alzheimer\u2019s disease in two longitudinally followed cohorts of older individuals. Alzheimer's Dement. 12, 815\u2013822 (2016).","journal-title":"Alzheimer's Dement."},{"key":"57032_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2016.03.005","volume":"43","author":"D Ciavardelli","year":"2016","unstructured":"Ciavardelli, D. et al. Medium-chain plasma acylcarnitines, ketone levels, cognition, and gray matter volumes in healthy elderly, mildly cognitively impaired, or Alzheimer\u2019s disease subjects. Neurobiol. Aging 43, 1\u201312 (2016).","journal-title":"Neurobiol. Aging"},{"key":"57032_CR29","doi-asserted-by":"publisher","first-page":"e0155694","DOI":"10.1371\/journal.pone.0155694","volume":"11","author":"A Cristofano","year":"2016","unstructured":"Cristofano, A. et al. Serum levels of acyl-carnitines along the continuum from normal to Alzheimer\u2019s Dementia. PLoS ONE 11, e0155694 (2016).","journal-title":"PLoS ONE"},{"key":"57032_CR30","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.jalz.2017.01.020","volume":"13","author":"JB Toledo","year":"2017","unstructured":"Toledo, J. B. et al. Metabolic network failures in Alzheimer\u2019s disease: a biochemical road map. Alzheimer\u2019s Dement. 13, 965\u2013984 (2017).","journal-title":"Alzheimer\u2019s Dement."},{"key":"57032_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-019-0551-7","volume":"11","author":"V Van Der Velpen","year":"2019","unstructured":"Van Der Velpen, V. et al. Systemic and central nervous system metabolic alterations in Alzheimer\u2019s disease. Alzheimers Res Ther. 11, 1\u201312 (2019).","journal-title":"Alzheimers Res Ther."},{"key":"57032_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14959-w","volume":"11","author":"M Arnold","year":"2020","unstructured":"Arnold, M. et al. Sex and APOE \u03b54 genotype modify the Alzheimer\u2019s disease serum metabolome. Nat. Commun. 11, 1148 (2020).","journal-title":"Nat. Commun."},{"key":"57032_CR33","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/bioinformatics\/btab656","volume":"38","author":"M Buyukozkan","year":"2022","unstructured":"Buyukozkan, M., Suhre, K. & Krumsiek, J. SGI: automatic clinical subgroup identification in omics datasets. Bioinformatics 38, 573\u2013576 (2022).","journal-title":"Bioinformatics"},{"key":"57032_CR34","doi-asserted-by":"publisher","unstructured":"Jack, C. R. et al. NIA-AA Research Framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 14, 535\u2013562. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018 (2018).","DOI":"10.1016\/j.jalz.2018.02.018"},{"key":"57032_CR35","doi-asserted-by":"publisher","first-page":"E1137","DOI":"10.1210\/jc.2012-3976","volume":"98","author":"M Wolf","year":"2013","unstructured":"Wolf, M. et al. Production and release of acylcarnitines by primary myotubes reflect the differences in fasting fat oxidation of the donors. J. Clin. Endocrinol. Metab. 98, E1137\u2013E1142 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"57032_CR36","doi-asserted-by":"publisher","first-page":"e11519","DOI":"10.1371\/journal.pone.0011519","volume":"5","author":"R Lehmann","year":"2010","unstructured":"Lehmann, R. et al. Medium chain acylcarnitines dominate the metabolite pattern in humans under moderate intensity exercise and support lipid oxidation. PLoS ONE 5, e11519 (2010).","journal-title":"PLoS ONE"},{"key":"57032_CR37","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH Van Dyck","year":"2023","unstructured":"Van Dyck, C. H. et al. Lecanemab in early Alzheimer\u2019s disease. N. Engl. J. Med. 388, 142\u2013143 (2023).","journal-title":"N. Engl. J. Med."},{"key":"57032_CR38","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/pr.2014.142","volume":"77","author":"A Gucciardi","year":"2015","unstructured":"Gucciardi, A. et al. Analysis and interpretation of acylcarnitine profiles in dried blood spot and plasma of preterm and full-term newborns. Pediatr. Res. 77, 36\u201347 (2015).","journal-title":"Pediatr. Res."},{"key":"57032_CR39","doi-asserted-by":"publisher","first-page":"e197978","DOI":"10.1001\/jamanetworkopen.2019.7978","volume":"2","author":"K Nho","year":"2019","unstructured":"Nho, K. et al. Association of altered liver enzymes with Alzheimer disease diagnosis, cognition, neuroimaging measures, and cerebrospinal fluid biomarkers. JAMA Netw. Open 2, e197978 (2019).","journal-title":"JAMA Netw. Open"},{"key":"57032_CR40","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.3945\/jn.108.103754","volume":"139","author":"SH Adams","year":"2009","unstructured":"Adams, S. H. et al. Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women. J. Nutr. 139, 1073\u20131081 (2009).","journal-title":"J. Nutr."},{"key":"57032_CR41","doi-asserted-by":"publisher","first-page":"6644","DOI":"10.1093\/hmg\/ddu372","volume":"23","author":"A Ramirez","year":"2014","unstructured":"Ramirez, A. et al. SUCLG2 identified as both a determinator of CSF A\u03b21\u201342 levels and an attenuator of cognitive decline in Alzheimer\u2019s disease. Hum. Mol. Genet. 23, 6644\u20136658 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"57032_CR42","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1093\/brain\/awz037","volume":"142","author":"EM Arenaza-Urquijo","year":"2019","unstructured":"Arenaza-Urquijo, E. M. et al. The metabolic brain signature of cognitive resilience in the 80+: beyond Alzheimer pathologies. Brain 142, 1134\u20131147 (2019).","journal-title":"Brain"},{"key":"57032_CR43","doi-asserted-by":"publisher","first-page":"3969","DOI":"10.1093\/brain\/awad159","volume":"146","author":"KP Kepp","year":"2023","unstructured":"Kepp, K. P., Robakis, N. K., H\u00f8ilund-Carlsen, P. F., Sensi, S. L. & Vissel, B. The amyloid cascade hypothesis: an updated critical review. Brain 146, 3969\u20133990 (2023).","journal-title":"Brain"},{"key":"57032_CR44","doi-asserted-by":"publisher","first-page":"102161","DOI":"10.1016\/j.arr.2023.102161","volume":"93","author":"A Granzotto","year":"2024","unstructured":"Granzotto, A. & Sensi, S. L. Once upon a time, the Amyloid Cascade Hypothesis. Ageing Res. Rev. 93, 102161 (2024).","journal-title":"Ageing Res. Rev."},{"key":"57032_CR45","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41392-021-00831-w","volume":"7","author":"H Zhu","year":"2022","unstructured":"Zhu, H. et al. Ketogenic diet for human diseases: the underlying mechanisms and potential for clinical implementations. Signal Transduct. Target Ther. 7, 11 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"57032_CR46","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.cell.2014.10.029","volume":"159","author":"JA Hawley","year":"2014","unstructured":"Hawley, J. A., Hargreaves, M., Joyner, M. J. & Zierath, J. R. Integrative biology of exercise. Cell 159, 738\u2013749 (2014).","journal-title":"Cell"},{"key":"57032_CR47","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s42255-020-0251-4","volume":"2","author":"M Hargreaves","year":"2020","unstructured":"Hargreaves, M. & Spriet, L. L. Skeletal muscle energy metabolism during exercise. Nat. Metab. 2, 817\u2013828 (2020).","journal-title":"Nat. Metab."},{"key":"57032_CR48","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cmet.2020.04.001","volume":"32","author":"AS Kulkarni","year":"2020","unstructured":"Kulkarni, A. S., Gubbi, S. & Barzilai, N. Benefits of metformin in attenuating the hallmarks of aging. Cell Metab. 32, 15\u201330 (2020).","journal-title":"Cell Metab."},{"key":"57032_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81349-7","volume":"11","author":"M Yang","year":"2021","unstructured":"Yang, M. et al. Inhibition of mitochondrial function by metformin increases glucose uptake, glycolysis and GDF-15 release from intestinal cells. Sci. Rep. 11, 2529 (2021).","journal-title":"Sci. Rep."},{"key":"57032_CR50","first-page":"288","volume":"27","author":"R Zakaria","year":"2016","unstructured":"Zakaria, R., Allen, K. J., Koplin, J. J., Roche, P. & Greaves, R. F. Advantages and challenges of dried blood spot analysis by mass spectrometry across the total testing process. EJIFCC 27, 288 (2016).","journal-title":"EJIFCC"},{"key":"57032_CR51","doi-asserted-by":"publisher","unstructured":"Bennett, D. A. et al. Religious orders study and rush memory and aging project. J. Alzheimer\u2019s Dis. 64, S161\u2013S189. https:\/\/doi.org\/10.3233\/JAD-179939 (2018).","DOI":"10.3233\/JAD-179939"},{"key":"57032_CR52","doi-asserted-by":"publisher","first-page":"1017.e1","DOI":"10.1016\/j.neurobiolaging.2011.09.033","volume":"33","author":"PL De Jager","year":"2012","unstructured":"De Jager, P. L. et al. A genome-wide scan for common variants affecting the rate of age-related cognitive decline. Neurobiol. Aging 33, 1017.e1\u20131017.e15 (2012).","journal-title":"Neurobiol. Aging"},{"key":"57032_CR53","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/ng.305","volume":"41","author":"MM Carrasquillo","year":"2009","unstructured":"Carrasquillo, M. M. et al. Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer\u2019s disease. Nat. Genet. 41, 192\u2013198 (2009).","journal-title":"Nat. Genet."},{"key":"57032_CR54","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"A Auton","year":"2015","unstructured":"Auton, A. et al. A global reference for human genetic variation. Nature 526, 68\u201374 (2015).","journal-title":"Nature"},{"key":"57032_CR55","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nmeth.2307","volume":"10","author":"O Delaneau","year":"2013","unstructured":"Delaneau, O., Zagury, J. F. & Marchini, J. Improved whole-chromosome phasing for disease and population genetic studies. Nat. Methods 10, 5\u20136 (2013).","journal-title":"Nat. Methods"},{"key":"57032_CR56","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1534\/g3.111.001198","volume":"1","author":"B Howie","year":"2011","unstructured":"Howie, B., Marchini, J. & Stephens, M. Genotype imputation with thousands of genomes. G3 Genes, Genomes, Genet. 1, 457\u2013470 (2011).","journal-title":"G3 Genes, Genomes, Genet."},{"key":"57032_CR57","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1055\/s-2005-858235","volume":"67","author":"R Holle","year":"2005","unstructured":"Holle, R., Happich, M., L\u00f6wel, H. & Wichmann, H. E. KORA\u2013a research platform for population based health research. Gesundheitswesen 67, S19\u2013S25 (2005).","journal-title":"Gesundheitswesen"},{"key":"57032_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002215","volume":"7","author":"K Mittelstrass","year":"2011","unstructured":"Mittelstrass, K. et al. Discovery of sexual dimorphisms in metabolic and genetic biomarkers. PLoS Genet. 7, e1002215 (2011).","journal-title":"PLoS Genet."},{"key":"57032_CR59","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1093\/aje\/kwk115","volume":"165","author":"TB Harris","year":"2007","unstructured":"Harris, T. B. et al. Age, gene\/environment Susceptibility\u2013Reykjavik Study: multidisciplinary applied phenomics. Am. J. Epidemiol. 165, 1076\u20131087 (2007).","journal-title":"Am. J. Epidemiol."},{"key":"57032_CR60","unstructured":"Wechsler, D. WAIS-R Manual: Wechsler Adult Intelligence Scale-Revised (Psychological Corporation, 1981)."},{"key":"57032_CR61","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1212\/WNL.0b013e3181cb3e25","volume":"74","author":"RC Petersen","year":"2010","unstructured":"Petersen, R. C. et al. Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology 74, 201\u2013209 (2010).","journal-title":"Neurology"},{"key":"57032_CR62","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle, B. W. et al. Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing. Nat. Genet. 51, 414\u2013430 (2019).","journal-title":"Nat. Genet."},{"key":"57032_CR63","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1080\/01621459.1963.10500845","volume":"58","author":"JH Ward","year":"1963","unstructured":"Ward, J. H. Hierarchical grouping to optimize an objective function. J. Am. Stat. Assoc. 58, 236\u2013244 (1963).","journal-title":"J. Am. Stat. Assoc."},{"key":"57032_CR64","doi-asserted-by":"publisher","unstructured":"Harrell, F. E. Multivariable modeling strategies. 63\u2013102. https:\/\/doi.org\/10.1007\/978-3-319-19425-7_4 (2015).","DOI":"10.1007\/978-3-319-19425-7_4"},{"key":"57032_CR65","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1177\/0049124102031001002","volume":"31","author":"A DeMaris","year":"2002","unstructured":"DeMaris, A. Explained variance in logistic regression. Sociol. Methods Res. 31, 27\u201374 (2002).","journal-title":"Sociol. Methods Res."},{"key":"57032_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-016-1323-z","volume":"17","author":"GE Hoffman","year":"2016","unstructured":"Hoffman, G. E. & Schadt, E. E. variancePartition: interpreting drivers of variation in complex gene expression studies. BMC Bioinform. 17, 483 (2016).","journal-title":"BMC Bioinform."},{"key":"57032_CR67","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s11682-012-9186-z","volume":"6","author":"PK Crane","year":"2012","unstructured":"Crane, P. K. et al. Development and assessment of a composite score for memory in the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI). Brain Imaging Behav. 6, 502\u2013516 (2012).","journal-title":"Brain Imaging Behav."},{"key":"57032_CR68","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s11682-012-9176-1","volume":"6","author":"LE Gibbons","year":"2012","unstructured":"Gibbons, L. E. et al. A composite score for executive functioning, validated in Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment. Brain Imaging Behav. 6, 517\u2013527 (2012).","journal-title":"Brain Imaging Behav."},{"key":"57032_CR69","doi-asserted-by":"crossref","first-page":"E334","DOI":"10.1212\/WNL.0000000000007821","volume":"93","author":"AC Van Loenhoud","year":"2019","unstructured":"Van Loenhoud, A. C. et al. Cognitive reserve and clinical progression in Alzheimer disease: a paradoxical relationship. Neurology 93, E334\u2013E346 (2019).","journal-title":"Neurology"},{"key":"57032_CR70","unstructured":"Fisher, R. A. Statistical Methods for Research Workers 11th ed. rev. https:\/\/psycnet.apa.org\/record\/1925-15003-000 (Oliver and Boyd, 1925)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57032-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57032-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57032-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T07:39:24Z","timestamp":1740382764000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57032-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,24]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["57032"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-57032-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.01.23.23297820","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,24]]},"assertion":[{"value":"19 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.J.S. is a member of the Scientific Advisory Board of Bayer Oncology and of the Dementia Advisory Board of Siemens Medical Solutions USA, Inc.; A.J.S received in-kind support from Avid Radiopharmaceuticals, a subsidiary of Eli Lilly (PET tracer precursor); A.J.S. received Editorial Office Support as Editor-in-Chief from Springer-Nature Publishing (Brain Imaging and Behavior). P.M.D. has received research grants (through Duke University) from Lilly, Avanir, Bausch, Alzheimer\u2019s Drug Discovery Foundation; P.M.D. has received advisory fees from Verily, Otsuka, Genomind, Cogniciti, Clearview, VitaKey, Neuronix, Neuroglee, and Transposon Therapeutics; P.M.D. owns shares or options in UMethod, Evidation Health, Transposon, Marvel Biome, and Advera Health; P.M.D. serves on the board of Apollo and is a co-inventor (through Duke University) on patents relating to dementia biomarkers, metabolomics, and therapies. R.K.D holds equity in Metabolon Inc. M.A., R.K.D., and G.K. are co-inventors (through Duke University\/Helmholtz Zentrum M\u00fcnchen) on patents on applications of metabolomics in diseases of the central nervous system; M.A., R.K.D., G.K., and J.K. hold equity in Chymia LLC and IP in PsyProtix\/atai Life Sciences N.V. that are exploring the potential for therapeutic applications targeting mitochondrial metabolism in treatment-resistant depression. JK is a confounder of iollo, advisor to Everfur, and advisor\/part-time employee at ExactRx. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1910"}}